CM
RARE icon

Castleark Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Castleark Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48,160
Closed -$4.05M – 356
2021
Q4 		$4.05M Buy
+48,160
New +$3.92M 0.15% 146
2021
Q1 		– Sell
-18,945
Closed -$2.62M – 365
2020
Q4 		$2.62M Sell
18,945
-64,190
-77% -$7.61M 0.1% 179
2020
Q3 		$6.83M Sell
83,135
-215
-0.3% -$17.8K 0.27% 108
2020
Q2 		$6.52M Sell
83,350
-850
-1% -$56.3K 0.28% 104
2020
Q1 		$3.74M Buy
+84,200
New +$4.37M 0.22% 123
2019
Q3 		– Sell
-56,995
Closed -$3.62M – 376
2019
Q2 		$3.62M Sell
56,995
-190
-0.3% -$12.1K 0.14% 175
2019
Q1 		$3.97M Buy
+57,185
New +$3.27M 0.15% 171

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return